Package 71610-934-92

{"route": ["ORAL"], "spl_id": "3dd660a7-5ba3-d993-e063-6394a90aeda9", "openfda": {"unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["3bc82d23-3950-f181-e063-6394a90ad565"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "270 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71610-934-92)", "package_ndc": "71610-934-92", "marketing_start_date": "20250902"}, {"sample": false, "description": "360 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71610-934-94)", "package_ndc": "71610-934-94", "marketing_start_date": "20250806"}, {"sample": false, "description": "540 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71610-934-98)", "package_ndc": "71610-934-98", "marketing_start_date": "20250818"}], "brand_name": "Phenytoin Sodium", "product_id": "71610-934_3dd660a7-5ba3-d993-e063-6394a90aeda9", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "71610-934", "generic_name": "Phenytoin Sodium", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA040684", "marketing_category": "ANDA", "marketing_start_date": "20060905", "listing_expiration_date": "20261231"}